Data / Form D filings / Key Proteo, Inc.
Key Proteo, Inc.: Form D filings
Key Proteo, Inc., a biotechnology company in Seattle, WA, filed 2 Form D notices with the SEC between 2023 and 2026. The latest, on October 23, 2026, reports $2.3 million sold of a $2.5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 720 BROADWAY, Seattle, WA, 98122
- Phone
- (206) 339-7515
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1977784
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | New notice | $2,500,000 | $2,330,000 | $170,000 | 3 | Mar 25, 2026 | sec.gov |
| May 19, 2023 | New notice | $5,000,000 | $3,028,381 | $1,971,619 | 3 | May 4, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| SIHOUN HAHN | Executive Officer, Director, Promoter | |
| JAE-HOON SONG | Director | |
| KOO JA-KYUM | Director |
Other biotechnology companies in Washington that filed recently
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
- Automera US Inc. $1 million · Aug 7, 2026
Every Form D from the week of Oct 19, 2026 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Key Proteo, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.